Europe Male Infertility Market By Treatment (Assisted Reproductive Technology & Varicocele Surgery and Medication), By Test (DNA Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Microscopic Examination, Sperm Agglutination, Sperm Penetration Assay and Other Tests), By Country, Industry Analysis and Forecast, 2020 - 2026
The Europe Male Infertility Market would witness market growth of 7.2% CAGR during the forecast period (2020-2026).
Elements of adult and gender identity can never be realized in infertile individuals due to the loss of pregnancy, childbirth, and lack of family and generational continuity and inclusiveness within their wider community. High levels of clinically relevant symptoms of depression and anxiety, suicidal thoughts, and a heavy conceptualization of grief impact infertile individuals. Mental health and psychosocial problems and resources need to address key factors of depression, such as poverty, sexual abuse, and infertility.
Growing rates of infertility worldwide and the introduction of assisted reproductive technologies (ARTs) are expected to push the demand for male infertility in the coming years. ARTs address a wide variety of infertility therapies that provide remedies for males facing issues such as reduced sperm count, irregular sperm quality, and poor motility. In addition, ARTs deliver a high success rate compared to drugs. The demand for male infertility is expected to see substantial development in the future due to technical developments in the area of assisted reproductive technology.
Increased demand for Assisted Reproductive Technologies [ART] is the most important reason for increasing income for male infertility worldwide. Assisted Reproductive Technologies [ART] assists males suffering from low sperm counts, sperm with reduced motility, or no sperm counts. In addition, a higher percentage of achievements related to medicine and improvement in expertise is expected to raise demand in the immediate future. It stimulates the growth of the market.
Based on Treatment, the market is segmented into Assisted Reproductive Technology & Varicocele Surgery and Medication. Based on Test, the market is segmented into DNA Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Microscopic Examination, Sperm Agglutination, Sperm Penetration Assay and Other Tests. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sanofi S.A., Bayer AG, Cadila Healthcare Ltd. (Zydus Cadila), Endo International PLC, Aytu BioScience, Inc., Vitrolife AB, SCSA Diagnostics, Inc., Andrology Solutions Limited, Halotech DNA SL, and Intas Pharmaceutical Ltd.
Scope of the Study
Market Segmentation:
By Treatment
Elements of adult and gender identity can never be realized in infertile individuals due to the loss of pregnancy, childbirth, and lack of family and generational continuity and inclusiveness within their wider community. High levels of clinically relevant symptoms of depression and anxiety, suicidal thoughts, and a heavy conceptualization of grief impact infertile individuals. Mental health and psychosocial problems and resources need to address key factors of depression, such as poverty, sexual abuse, and infertility.
Growing rates of infertility worldwide and the introduction of assisted reproductive technologies (ARTs) are expected to push the demand for male infertility in the coming years. ARTs address a wide variety of infertility therapies that provide remedies for males facing issues such as reduced sperm count, irregular sperm quality, and poor motility. In addition, ARTs deliver a high success rate compared to drugs. The demand for male infertility is expected to see substantial development in the future due to technical developments in the area of assisted reproductive technology.
Increased demand for Assisted Reproductive Technologies [ART] is the most important reason for increasing income for male infertility worldwide. Assisted Reproductive Technologies [ART] assists males suffering from low sperm counts, sperm with reduced motility, or no sperm counts. In addition, a higher percentage of achievements related to medicine and improvement in expertise is expected to raise demand in the immediate future. It stimulates the growth of the market.
Based on Treatment, the market is segmented into Assisted Reproductive Technology & Varicocele Surgery and Medication. Based on Test, the market is segmented into DNA Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Microscopic Examination, Sperm Agglutination, Sperm Penetration Assay and Other Tests. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sanofi S.A., Bayer AG, Cadila Healthcare Ltd. (Zydus Cadila), Endo International PLC, Aytu BioScience, Inc., Vitrolife AB, SCSA Diagnostics, Inc., Andrology Solutions Limited, Halotech DNA SL, and Intas Pharmaceutical Ltd.
Scope of the Study
Market Segmentation:
By Treatment
- Assisted Reproductive Technology & Varicocele Surgery and
- Medication
- DNA Fragmentation Technique
- Oxidative Stress Analysis
- Computer Assisted Semen Analysis
- Microscopic Examination
- Sperm Agglutination
- Sperm Penetration Assay and
- Other Tests
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Sanofi S.A.
- Bayer AG
- Cadila Healthcare Ltd. (Zydus Cadila)
- Endo International PLC
- Aytu BioScience, Inc.
- Vitrolife AB
- SCSA Diagnostics, Inc.
- Andrology Solutions Limited
- Halotech DNA SL
- Intas Pharmaceutical Ltd.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Male Infertility Market, by Treatment
1.4.2 Europe Male Infertility Market, by Tests
1.4.3 Europe Male Infertility Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. EUROPE MALE INFERTILITY MARKET BY TREATMENT
3.1 Europe Assisted Reproductive Technology and Varicocele Surgery Market by Country
3.2 Europe Medication Market by Country
CHAPTER 4. EUROPE MALE INFERTILITY MARKET BY TEST
4.1 Europe DNA Fragmentation Technique Market by Country
4.2 Europe Oxidative Stress Analysis Market by Country
4.3 Europe Computer Assisted Semen Analysis Market by Country
4.4 Europe Microscopic Examination Market by Country
4.5 Europe Sperm Agglutination Market by Country
4.6 Europe Sperm Penetration Assay Market by Country
4.7 Europe Other Test Market by Country
CHAPTER 5. EUROPE MALE INFERTILITY MARKET BY COUNTRY
5.1 Germany Male Infertility Market
5.1.1 Germany Male Infertility Market by Treatment
5.1.2 Germany Male Infertility Market by Test
5.2 UK Male Infertility Market
5.2.1 UK Male Infertility Market by Treatment
5.2.2 UK Male Infertility Market by Test
5.3 France Male Infertility Market
5.3.1 France Male Infertility Market by Treatment
5.3.2 France Male Infertility Market by Test
5.4 Russia Male Infertility Market
5.4.1 Russia Male Infertility Market by Treatment
5.4.2 Russia Male Infertility Market by Test
5.5 Spain Male Infertility Market
5.5.1 Spain Male Infertility Market by Treatment
5.5.2 Spain Male Infertility Market by Test
5.6 Italy Male Infertility Market
5.6.1 Italy Male Infertility Market by Treatment
5.6.2 Italy Male Infertility Market by Test
5.7 Rest of Europe Male Infertility Market
5.7.1 Rest of Europe Male Infertility Market by Treatment
5.7.2 Rest of Europe Male Infertility Market by Test
CHAPTER 6. COMPANY PROFILES
6.1 Sanofi S.A.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Bayer AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cadila Healthcare Ltd. (Zydus Cadila)
6.3.1 Company Overview
6.3.1 Financial Analysis
6.3.2 Regional Analysis
6.3.3 Research & Development Expense
6.4 Endo International PLC
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Expense
6.5 Aytu BioScience, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and Mergers:
6.5.5.2 Partnerships, Collaborations, and Agreements:
6.6 Vitrolife AB
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expenses
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 SCSA Diagnostics, Inc.
6.7.1 Company Overview
6.8 Andrology Solutions Limited
6.8.1 Company Overview
6.9 Halotech DNA SL
6.9.1 Company Overview
6.1 Intas Pharmaceutical Ltd.
6.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Male Infertility Market, by Treatment
1.4.2 Europe Male Infertility Market, by Tests
1.4.3 Europe Male Infertility Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. EUROPE MALE INFERTILITY MARKET BY TREATMENT
3.1 Europe Assisted Reproductive Technology and Varicocele Surgery Market by Country
3.2 Europe Medication Market by Country
CHAPTER 4. EUROPE MALE INFERTILITY MARKET BY TEST
4.1 Europe DNA Fragmentation Technique Market by Country
4.2 Europe Oxidative Stress Analysis Market by Country
4.3 Europe Computer Assisted Semen Analysis Market by Country
4.4 Europe Microscopic Examination Market by Country
4.5 Europe Sperm Agglutination Market by Country
4.6 Europe Sperm Penetration Assay Market by Country
4.7 Europe Other Test Market by Country
CHAPTER 5. EUROPE MALE INFERTILITY MARKET BY COUNTRY
5.1 Germany Male Infertility Market
5.1.1 Germany Male Infertility Market by Treatment
5.1.2 Germany Male Infertility Market by Test
5.2 UK Male Infertility Market
5.2.1 UK Male Infertility Market by Treatment
5.2.2 UK Male Infertility Market by Test
5.3 France Male Infertility Market
5.3.1 France Male Infertility Market by Treatment
5.3.2 France Male Infertility Market by Test
5.4 Russia Male Infertility Market
5.4.1 Russia Male Infertility Market by Treatment
5.4.2 Russia Male Infertility Market by Test
5.5 Spain Male Infertility Market
5.5.1 Spain Male Infertility Market by Treatment
5.5.2 Spain Male Infertility Market by Test
5.6 Italy Male Infertility Market
5.6.1 Italy Male Infertility Market by Treatment
5.6.2 Italy Male Infertility Market by Test
5.7 Rest of Europe Male Infertility Market
5.7.1 Rest of Europe Male Infertility Market by Treatment
5.7.2 Rest of Europe Male Infertility Market by Test
CHAPTER 6. COMPANY PROFILES
6.1 Sanofi S.A.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Bayer AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cadila Healthcare Ltd. (Zydus Cadila)
6.3.1 Company Overview
6.3.1 Financial Analysis
6.3.2 Regional Analysis
6.3.3 Research & Development Expense
6.4 Endo International PLC
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Expense
6.5 Aytu BioScience, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and Mergers:
6.5.5.2 Partnerships, Collaborations, and Agreements:
6.6 Vitrolife AB
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expenses
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 SCSA Diagnostics, Inc.
6.7.1 Company Overview
6.8 Andrology Solutions Limited
6.8.1 Company Overview
6.9 Halotech DNA SL
6.9.1 Company Overview
6.1 Intas Pharmaceutical Ltd.
6.10.1 Company Overview
LIST OF TABLES
TABLE 1 EUROPE MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 2 EUROPE MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 3 EUROPE MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 4 EUROPE MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 5 EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 EUROPE MEDICATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 EUROPE MEDICATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 EUROPE MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 10 EUROPE MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 11 EUROPE DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 EUROPE DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 EUROPE OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 EUROPE OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 EUROPE COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 EUROPE COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 EUROPE MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 EUROPE MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 EUROPE SPERM AGGLUTINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 EUROPE SPERM AGGLUTINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 EUROPE SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 EUROPE SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 EUROPE OTHER TEST MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 EUROPE OTHER TEST MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 EUROPE MALE INFERTILITY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 EUROPE MALE INFERTILITY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 GERMANY MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 28 GERMANY MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 29 GERMANY MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 30 GERMANY MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 31 GERMANY MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 32 GERMANY MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 33 UK MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 34 UK MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 35 UK MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 36 UK MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 37 UK MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 38 UK MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 39 FRANCE MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 40 FRANCE MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 41 FRANCE MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 42 FRANCE MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 43 FRANCE MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 44 FRANCE MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 45 RUSSIA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 46 RUSSIA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 47 RUSSIA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 48 RUSSIA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 49 RUSSIA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 50 RUSSIA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 51 SPAIN MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 52 SPAIN MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 53 SPAIN MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 54 SPAIN MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 55 SPAIN MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 56 SPAIN MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 57 ITALY MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 58 ITALY MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 59 ITALY MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 60 ITALY MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 61 ITALY MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 62 ITALY MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 63 REST OF EUROPE MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 64 REST OF EUROPE MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 65 REST OF EUROPE MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 66 REST OF EUROPE MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 67 REST OF EUROPE MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 68 REST OF EUROPE MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 69 KEY INFORMATION – SANOFI S.A.
TABLE 70 KEY INFORMATION – BAYER AG
TABLE 71 KEY INFORMATION – CADILA HEALTHCARE LTD.
TABLE 72 KEY INFORMATION – ENDO INTERNATIONAL PLC
TABLE 73 KEY INFORMATION – AYTU BIOSCIENCE, INC.
TABLE 74 KEY INFORMATION – VITROLIFE AB
TABLE 75 KEY INFORMATION – SCSA DIAGNOSTICS, INC.
TABLE 76 KEY INFORMATION – ANDROLOGY SOLUTIONS LIMITED
TABLE 77 KEY INFORMATION – HALOTECH DNA SL
TABLE 78 KEY INFORMATION – INTAS PHARMACEUTICAL LTD.
TABLE 1 EUROPE MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 2 EUROPE MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 3 EUROPE MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 4 EUROPE MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 5 EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 EUROPE MEDICATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 EUROPE MEDICATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 EUROPE MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 10 EUROPE MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 11 EUROPE DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 EUROPE DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 EUROPE OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 EUROPE OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 EUROPE COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 EUROPE COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 EUROPE MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 EUROPE MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 EUROPE SPERM AGGLUTINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 EUROPE SPERM AGGLUTINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 EUROPE SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 EUROPE SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 EUROPE OTHER TEST MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 EUROPE OTHER TEST MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 EUROPE MALE INFERTILITY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 EUROPE MALE INFERTILITY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 GERMANY MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 28 GERMANY MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 29 GERMANY MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 30 GERMANY MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 31 GERMANY MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 32 GERMANY MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 33 UK MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 34 UK MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 35 UK MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 36 UK MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 37 UK MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 38 UK MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 39 FRANCE MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 40 FRANCE MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 41 FRANCE MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 42 FRANCE MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 43 FRANCE MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 44 FRANCE MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 45 RUSSIA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 46 RUSSIA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 47 RUSSIA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 48 RUSSIA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 49 RUSSIA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 50 RUSSIA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 51 SPAIN MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 52 SPAIN MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 53 SPAIN MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 54 SPAIN MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 55 SPAIN MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 56 SPAIN MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 57 ITALY MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 58 ITALY MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 59 ITALY MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 60 ITALY MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 61 ITALY MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 62 ITALY MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 63 REST OF EUROPE MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 64 REST OF EUROPE MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 65 REST OF EUROPE MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 66 REST OF EUROPE MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 67 REST OF EUROPE MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 68 REST OF EUROPE MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 69 KEY INFORMATION – SANOFI S.A.
TABLE 70 KEY INFORMATION – BAYER AG
TABLE 71 KEY INFORMATION – CADILA HEALTHCARE LTD.
TABLE 72 KEY INFORMATION – ENDO INTERNATIONAL PLC
TABLE 73 KEY INFORMATION – AYTU BIOSCIENCE, INC.
TABLE 74 KEY INFORMATION – VITROLIFE AB
TABLE 75 KEY INFORMATION – SCSA DIAGNOSTICS, INC.
TABLE 76 KEY INFORMATION – ANDROLOGY SOLUTIONS LIMITED
TABLE 77 KEY INFORMATION – HALOTECH DNA SL
TABLE 78 KEY INFORMATION – INTAS PHARMACEUTICAL LTD.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
